Aethlon Medical, Inc.(AEMD)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-18 | Shah Chetan Director | Sale | -26,852 | -61.74%16,641 | $2.11 | $56,580 | View SEC filing | |
| 2010-04-14 | BROENNIMAN EDWARD G Director | Sale | -100,200 | -26.20%282,174 | $0.35 | $34,801 | View SEC filing | |
| 2010-04-09 | BARRY FRANKLYN S JR Director | Sale | -27,800 | -20.69%106,593 | $0.35 | $9,742 | View SEC filing | |
| 2010-04-06 | BROENNIMAN EDWARD G Director | Sale | -99,800 | -20.70%382,374 | $0.40 | $39,495 | View SEC filing | |
| 2010-04-02 | BARRY FRANKLYN S JR Director | Sale | -122,200 | -47.62%134,393 | $0.39 | $47,832 | View SEC filing | |
| 2009-12-03 | BROENNIMAN EDWARD G Director | Sale | -100,000 | -17.18%482,174 | $0.35 | $35,350 | View SEC filing | |
| 2007-04-13 | BROENNIMAN EDWARD G Director | Sale | -100,000 | -42.40%135,874 | $0.76 | $76,175 | View SEC filing | |
| 2006-03-23 | BROENNIMAN EDWARD G Director | Sale | -20,000 | -7.82%235,874 | $0.89 | $17,843 | View SEC filing |
1-8 of 8